Colorectal cancer (CRC) is curable in more than 90% of cases if diagnosed while still localized. Nevertheless, this disease is one of the most frequent causes of cancer-related death in the industrialized world. The dilemma: screening options such as colonoscopy and FOB testing exist but patient compliance is low. The Epi proColon Early Detection Assay offers a new way of detecting colorectal cancer early: convenient and easy. 

To find out where to get the test please click here

For further information follow the links below:

Laboratories

Medical Professionals

Patients